Stent thrombosis and antiplatelet therapy: A review of 3,004 consecutive patients in a single centre

British Journal of Cardiology

Volumn 14, Issue 4, 2007, Pages 234-236

  Curzen, Nick ^a,b   Morton, Geraint ^a   Hobson, Alex ^a   Simpson, Iain ^a   Calver, Alison ^a   Gray, Huon ^a   Dawkins, Keith D ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Antiplatelet therapy; Percutaneous coronary intervention; Stent thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL;

COMBINATION CHEMOTHERAPY; CORONARY STENT; DRUG ELUTING STENT; HEART INFARCTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MONOTHERAPY; PATIENT EDUCATION; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; THROMBOSIS;

EID: 35648971536     PISSN: 09696113     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. Colombo A, Grube E, Koglin J et al. Early and late stent thrombosis after paclitaxel-eluting stents: analysis from the integrated TAXUS randomised trial program. J Am Coll Cardiol 2006; 47(suppl A):221A.
2. Rodriguez A, Mieres J, Fernandez-Pereira C, Vigo C. Coronary stent thrombosis in the current drug-eluting stent era: insights from the ERACI III trial. J Am Coll Cardiol 2006;47:205-7.
3. Ong A, McFadden E, Regar E et al. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 2005;45:2088-92.
4. Joner M, Finn A, Farb A et al. Pathology of drug-eluting stents in man: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006;48:193-202.
5. Pfisterer M, Brunner-La Rocca H, Buser P et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents. J Am Coll Cardiol 2006;48:2584-91.
6. McFadden E, Stabile E, Regar E et al. Late stent thrombosis in drug-eluting stents after discontinuation of antiplatelet therapy. Lancet 2004;364:1519-21.
7. Ferrari E, Benhamou M, Cerboni P et al. Coronary syndromes following aspirin withdrawal. A special risk for late stent thrombosis. J Am Coll Cardiol 2005;45:456-9.
8. Gurbel P, Bliden K, Samara W et al. Clopidogrel effect on platelet reactivity in patients with stent thrombosis. Results from the CREST STUDY. J Am Coll Cardiol 2005;46:1827-32.
9. Moreno R, Fernandez C, Hernandez R et al. Drug-eluting stent thrombosis. Results from a pooled analysis including 10 randomised studies. J Am Coll Cardiol 2005;45:954-9.
10. Farb A, Burke A, Kolodgie F et al. Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation 2003;108:1701-6.
11. Joner M, Finn A, Farb A et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006;48:193-202.
12. Kotani J, Awata M, Nanto S et al. Incomplete neointimal coverage of sirolimus-eluting stents. J Am Coll Cardiol 2006; 47:2108-11.
13. Swallow RA, Agarwala RA, Dawkins KD, Curzen NP. Thromboelastography: potential bedside tool to assess the effects of antiplatelet therapy? Platelets 2006;17:385-92.